We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

51 hedge funds and large institutions have $97.5M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

19% more funds holding

Funds holding: 43 → 51 (+8)

0% less capital invested

Capital invested by funds: $97.7M → $97.5M (-$207K)

7% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 15

Holders
51
Holders Change
+8
Holders Change %
+18.6%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$392K
2
JG
Jefferies Group
New York
+$258K
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$209K
4
BlackRock
BlackRock
New York
+$164K
5
Millennium Management
Millennium Management
New York
+$118K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.77M
2
BCM
Bridgeway Capital Management
Texas
-$334K
3
JP Morgan Chase
JP Morgan Chase
New York
-$317K
4
First Trust Advisors
First Trust Advisors
Illinois
-$111K
5
SC
Samlyn Capital
New York
-$99.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$58.7M – – –
SC
2
Samlyn Capital
New York
$7.03M -$99.5K -13,120 -2%
BlackRock
3
BlackRock
New York
$6.54M +$164K +21,592 +3%
Franklin Resources
4
Franklin Resources
California
$6.36M – – –
LPC
5
Lion Point Capital
New York
$4.54M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.03M -$17.6K -2,325 -0.7%
JP Morgan Chase
7
JP Morgan Chase
New York
$2.91M -$317K -41,801 -12%
State Street
8
State Street
Massachusetts
$1.43M -$3.19K -420 -0.3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.24M +$2.46K +324 +0.2%
Northern Trust
10
Northern Trust
Illinois
$1.23M -$43.8K -5,769 -4%
BCM
11
Bridgeway Capital Management
Texas
$766K -$334K -44,000 -34%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$574K +$392K +51,719 +450%
FT
13
Fiduciary Trust
Massachusetts
$345K – – –
JG
14
Jefferies Group
New York
$308K +$258K +33,948 New
N
15
Nuveen
North Carolina
$269K +$3.58K +472 +2%
Goldman Sachs
16
Goldman Sachs
New York
$266K -$78.3K -10,323 -26%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$265K +$1.81K +239 +0.8%
Russell Investments Group
18
Russell Investments Group
United Kingdom
$250K +$209K +27,598 New
Charles Schwab
19
Charles Schwab
California
$236K – – –
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$165K – – –
Wells Fargo
21
Wells Fargo
California
$112K -$23.9K -3,155 -20%
TRCT
22
Tower Research Capital (TRC)
New York
$108K +$75.3K +9,930 +501%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$104K -$15.7K -2,075 -15%
IWM
24
IHT Wealth Management
Illinois
$104K -$1.52K -200 -2%
Barclays
25
Barclays
United Kingdom
$77K +$14.3K +1,888 +29%
1
2 3

LOGC Hedge Fund Activity: Q3 2020 in Review

51 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q3 2020, worth a combined $97.5M — down 0.21% from $97.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LOGC positions and 3 closed out — a net gain of 8 holders — while 14 added to existing stakes and 15 trimmed.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $392K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $6.77M sold.

  • 51 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q3 2020, up from 43 in Q2 2020.
  • Funds reported $97.5M of LogicBio Therapeutics, Inc. Common Stock stock for Q3 2020, down 0.21% quarter-over-quarter.
  • 11 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q3 2020 and 3 closed out, a net change of +8 holders.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q3 2020 was Jacobs Levy Equity Management, an estimated $392K added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q3 2020 was Adage Capital Partners, an estimated $6.77M sold.

Based on aggregated 13F filings for Q3 2020.